VIROPHARMA INC
DelistedCIK 946840fmd_1R2R6N84ZJR43NS9N2EV6HZ8F0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2013, 16 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Cost of revenue | 40 | 61 | 80 | 109 |
| Research and development | 52 | 40 | 66 | 68 |
| Selling, general and administrative | 89 | 96 | 128 | 174 |
| Operating income | 32 | 212 | 222 | 33 |
| Interest expense | 12 | 12 | 13 | 14 |
| Interest and investment income | 0 | 0 | 1 | 1 |
| Other non-operating income (expense) | – | 0 | (2) | (1) |
| Income before taxes | 30 | 201 | 208 | 19 |
| Income tax expense | 41 | 75 | 67 | 13 |
| Net income from continuing operations | (11) | 126 | 141 | 6 |
| Net income | (11) | 126 | 141 | – |
| Net income to common shareholders | – | 126 | 141 | 6 |